News - Roche, Ophthotech

Filter

Current filters:

RocheOphthotech

Popular Filters

Strong uptake of Regeneron/Bayer wet AMD drug Eylea in USA, but Avastin still leads

11-07-2013

The majority of wet age-related macular degeneration (AMD) patients are administered their first intravitreal…

AllerganAvastinBayerBiotechnologyEyleaFovistaLucentisMarkets & MarketingNorth AmericaOphthalmicsOphthotechPharmaceuticalRegeneronRoche

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top